Panacea Biotec Limited (BOM:531349)
India · Delayed Price · Currency is INR 346.70
+15.60 (4.71%)
At close: Apr 15, 2026
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 21.25 billion as of April 15, 2026. Its market cap has decreased by -22.51% in one year.
Market Cap
21.25B
Enterprise Value
20.59B
Revenue
6.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
346.70
Market Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has increased from 21.08B to 21.25B, an increase of 0.83%. That is a compound annual growth rate of 0.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 21.25B | -7.80% |
| Dec 31, 2025 | 23.05B | -10.11% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Drugs | 32.22B |
| Titan Biotech | 16.94B |
| Hester Biosciences | 12.34B |
| Genesis IBRC India | 3.49B |
| Zenotech Laboratories | 2.88B |
| Bharat Immunologicals & Biologicals Corporation | 728.01M |
| Transgene Biotek | 200.79M |
| Hindustan Bio Sciences | 94.20M |